BackNewAmsterdam Pharma Company NV Overview

NewAmsterdam Pharma Company NV Current Assets

Track NewAmsterdam Pharma Company NV's current assets ($660M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$658.04M
↓ 19.49% YoYΔ $-159.26M vs prior year quarter

Peer average

Loading

NewAmsterdam Pharma Company NV Current Assets History

Loading

NewAmsterdam Pharma Company NV vs. peers: Current Assets Comparison

Loading

NewAmsterdam Pharma Company NV Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NewAmsterdam Pharma Company NV (NAMS) FAQ

NewAmsterdam Pharma Company NV (NAMS) currently reports a current assets of $660M as of March 2026. That compares with $820M in the prior-year period — down 19.5% year over year. Use the charts on this page to explore NewAmsterdam Pharma Company NV's current assets history and peer comparisons.

NewAmsterdam Pharma Company NV's current assets decreased from $820M to $660M — a 19.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NewAmsterdam Pharma Company NV reported $660M in current assets as of March 2026. That compares with $820M in the prior-year period — down 19.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $660M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NewAmsterdam Pharma Company NV, and consider following NAMS for alerts when major investors trade the stock.